Drug and Device Manufacturer Communications With Payors Formulary Committees and Similar Entities - Questions and Answers - Guidance for Industry and Review Staff
FDA-2016-D-1307-0035Other
Comments
1
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
0%
0% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Drug and Device Manufacturer Communications With Payors Formulary Committees and Similar Entities - Questions and Answers - Guidance for Industry and Review Staff
- Posted
- Nov 2, 2018
- Comment period
- Nov 2, 2018 – ?
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
0%
Net support
Other1
Aggregates include form-letter campaigns. Excluding them, net support is 0% across organic comments.
Who commented
Breakdown by commenter type.
Individual
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Nov 2, 2018
Jun 1
Support0Oppose0Other1
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
0%
0%
100%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.